BLM and pachyonychia congenita: A similar observation with the BLMAsh and p.Gln548Ter mutations was observed in the prostate cancer (PC) cells wherein no significant effect on the survival was seen even though the frequency of truncating BLM germline mutations was higher in advanced PC patients as compared to the control populations (Antczak et al., 2013; Bononi et al., 2020; Ledet et al., 2020).